Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population
Conclusion: Our findings revealed that the Sinopharm and Oxford-AstraZeneca vaccines are effective in the production of neutralizing antibodies in healthy subjects and patients with autoimmune disorders undergoing immunosuppressive therapies without considerable reactogenicity.PMID:38494849 | PMC:PMC10946076 | DOI:10.1177/03946320241239202
Source: International Journal of Immunopathology and Pharmacology - Category: Allergy & Immunology Authors: Amin Moradi Hasan-Abad Mohsen Arbabi Hamidreza Gilasi Hossein Motedayyen Source Type: research
More News: Allergy & Immunology | AstraZeneca | Autoimmune Disease | Covid Vaccine | COVID-19 | Drugs & Pharmacology | Iran Health | SARS | Study | Vaccines